Literature DB >> 25427085

Heparin-coated dialyzer membranes: is non-inferiority good enough?

Björn K I Meijers1, Ruben Poesen2, Pieter Evenepoel1.   

Abstract

Evidence on the optimal anticoagulation regimen for hemodialysis in patients at high bleeding risk is scarce. The HepZero study is the first large multinational study comparing two different anticoagulation strategies to avoid systemic heparinization. The use of a heparin-coated dialysis membrane proved to be non-inferior to saline infusion. Superiority of either treatment, however, could not be demonstrated. These findings challenge current guidelines but equally raise questions on the choice of either strategy as compared with regional citrate anticoagulation.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25427085     DOI: 10.1038/ki.2014.315

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  4 in total

Review 1.  [Regional citrate anticoagulation in renal replacement therapy in the intensive care station : Recommendations from the renal section of the DGIIN, ÖGIAIN and DIVI].

Authors:  M Schmitz; M Joannidis; D Czock; S John; A Jörres; S J Klein; M Oppert; V Schwenger; J Kielstein; A Zarbock; D Kindgen-Milles; C Willam
Journal:  Med Klin Intensivmed Notfmed       Date:  2018-05-08       Impact factor: 0.840

2.  Polyethyleneimine-treated polyacrylonitrile membrane hemofilter for critically ill patients receiving anticoagulant-free prolonged intermittent renal replacement therapy: a single-center, prospective, self-controlled pilot study.

Authors:  Tao Su; Qizhuang Jin; Zhongyuan Liu
Journal:  BMC Nephrol       Date:  2017-06-30       Impact factor: 2.388

3.  Prescribing Hemodialysis or Hemodiafiltration: When One Size Does Not Fit All the Proposal of a Personalized Approach Based on Comorbidity and Nutritional Status.

Authors:  Giorgina Barbara Piccoli; Louise Nielsen; Lurilyn Gendrot; Antioco Fois; Emanuela Cataldo; Gianfranca Cabiddu
Journal:  J Clin Med       Date:  2018-10-08       Impact factor: 4.241

4.  Strategies for asymmetrical triacetate dialyser heparin-free effective haemodialysis: the SAFE study.

Authors:  Ines Vandenbosch; Sander Dejongh; Kathleen Claes; Bert Bammens; Katrien De Vusser; Amaryllis Van Craenenbroeck; Dirk Kuypers; Pieter Evenepoel; Björn Meijers
Journal:  Clin Kidney J       Date:  2020-11-28
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.